|Bid||62.54 x 100|
|Ask||63.51 x 100|
|Day's Range||66.27 - 67.11|
|52 Week Range||49.59 - 72.58|
|PE Ratio (TTM)||51.54|
|Earnings Date||Apr 24, 2018 - Apr 30, 2018|
|Forward Dividend & Yield||0.64 (0.96%)|
|1y Target Est||75.27|
Baxter International Inc. will present at the Barclays Global Healthcare Conference on Tuesday, March 13, 2018, in Miami, Fla. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:15 a.m.
What Can Investors Expect from Becton Dickinson in Fiscal 2018? Becton Dickinson (BDX) announced its fiscal 2018 guidance, which includes the company’s recently acquired Bard business, during the company’s 1Q18 earnings release. BD expects to register adjusted diluted EPS (earnings per share) of $10.85 to $11, which represents YoY (year-over-year) growth of 15% to 16%.
What Can Investors Expect from Becton Dickinson in Fiscal 2018? Becton Dickinson (BDX) released its 1Q18 earnings results on February 6, 2018. For detailed information on the earnings results, read Becton Dickinson’s Fiscal 1Q18 Results Beat Analyst Estimates.
Baxter International Inc. will present at the Raymond James & Associates 39th Annual Institutional Investors Conference on Tuesday, March 6, 2018, in Orlando, Fla. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 4:35 p.m.
What's Next for Abbott Laboratories after a Stellar 2017?The impact of 4Q17 earnings release on ABT’s stock price performance
Today I will be providing a simple run-through of the discounted cash flows (DCF) method to estimate the attractiveness of Baxter International Inc (NYSE:BAX) as an investment opportunity. If youRead More...
Baxter International Inc on Thursday forecast 2018 earnings largely ahead of analysts' estimates and said it would continue to be active on the acquistion front and repurchase more shares through the year. "Any stock which had a guidance coming in-line or below has (seen) a negative reaction," Evercore ISI analyst Vijay Kumar told Reuters, adding that the same had happened to Intuitive Surgical Inc and Illumina Inc in January.
The Deerfield, Illinois-based company said it had a loss of 13 cents per share. Earnings, adjusted for non-recurring costs and to account for discontinued operations, came to 64 cents per share. The results ...
Baxter International Inc reported quarterly loss versus year-ago profit as the hospital products maker took a charge of $354 million due to changes in the U.S. tax law. Baxter posted net loss of $71 million, ...
Baxter International Inc. today reported results for the fourth quarter and full-year ended December 31, 2017, and provided its financial guidance for 2018.
NEW YORK, NY / ACCESSWIRE / February 1, 2018 / Baxter International Inc. (NYSE: BAX ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 1, 2018 at 8:30 AM Eastern ...
As part of the amended tax policy, corporate tax rates are lowered to 21% from 35%, offering a huge relief to medical device giants.
Baxter International Inc. will present at the RBC Capital Markets 2018 Global Healthcare Conference on Wednesday, February 21, 2018, in New York. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:30 a.m.
Baxter International informed customers on Wednesday that it has been given approval by U.S. regulators to import large saline bags from its plant in Mexico in an effort to ease hospital shortages of the product as the nation faces a severe flu season. Supply issues related to Baxter's small-volume saline bags - which are produced in the U.S. market in Puerto Rico - have begun to ease as production there improves, Scott Luce, general manager of Baxter's U.S. Hospital products division, wrote in a letter addressed to customers and seen by Reuters.